SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the expansion of Twist Express Genes, a new leading gene synthesis service with an order to shipping turnaround starting at five business days1, to include larger DNA preparations up to 1 milligram..

加利福尼亚州南旧金山——（商业新闻短讯）——Twist Bioscience Corporation（NASDAQ:TWST）是一家利用其硅平台提供高质量合成DNA，从而使客户获得成功的公司，今天宣布扩展Twist Express Genes，这是一家新的领先基因合成服务，订单从五个工作日开始发货周转1，包括高达1毫克的较大DNA制剂。。

The Express Genes offering, initially launched in November 2023, now extends to larger midiprep (10μg to 100 μg) and maxiprep (100μg to 1mg) DNA preparations. As with Twist standard speed Clonal Genes, all Twist Express Genes are NGS-verified as clonally perfect.

最初于2023年11月推出的Express Genes产品现已扩展到更大的midiprep（10μg至100μg）和maxiprep（100μg至1mg）DNA制剂。与Twist标准速度克隆基因一样，所有Twist表达基因均被NGS验证为克隆完美。

“Since the initial launch of our Express Genes service in November, we have received positive and enthusiastic feedback from existing customers on our consistent and rapid turnaround time. By expanding Express Genes to include midiprep and maxiprep, we can now offer rapid gene synthesis at all gene prep scales, enabling large scale experimentation for pharmaceutical, biotechnology, academic and industrial chemical researchers,” said Emily M.

“自从我们的Express Genes服务于11月首次推出以来，我们在持续快速的周转时间方面收到了现有客户的积极而热情的反馈。通过将Express Genes扩展到包括midiprep和maxiprep，我们现在可以在所有gene prep规模上提供快速的基因合成，从而实现制药，生物技术，学术和工业化学研究人员说。

Leproust, Ph.D., CEO and co-founder of Twist Bioscience. “With the expanded offering of Twist Express Genes, more researchers can gain access to Twist genes fast and at scale, including those using alternative providers and those cloning their own genes. The ability to order and receive synthetic DNA fast and at scale means more time for cutting-edge research, more make-test-learn cycles, and an accelerated journey to game-changing discoveries.”.

Leproust博士，Twist Bioscience首席执行官兼联合创始人。“随着Twist Express基因的扩展，更多的研究人员可以快速大规模地获得Twist基因，包括那些使用替代供应商的研究人员和克隆自己基因的研究人员。快速大规模订购和接收合成DNA的能力意味着有更多的时间进行前沿研究，更多地进行测试学习周期，以及加速改变游戏规则的发现。”。

Twist leverages its ability to miniaturize the chemical reaction to create DNA using its silicon-based DNA synthesis platform along with expertise, software, optimized processes and the expanded layout of its Wilsonville facility to deliver Clonal Genes and Gene Fragments at scale and with rapid turnaround times.

Twist利用其基于硅的DNA合成平台以及专业知识，软件，优化过程和Wilsonville设施的扩展布局，利用其将化学反应小型化以产生DNA的能力，以大规模和快速的周转时间提供克隆基因和基因片段。

Twist’s Express Genes are offered with dynamic pricing, which reflects market demand and manufacturing capacity in a responsive premium price. Customers are able to quickly and easily place orders for Express Genes through Twist’s ecommerce platform..

Twist的Express Genes提供动态定价，以响应溢价反映市场需求和制造能力。客户可以通过Twist的电子商务平台快速轻松地订购Express Genes。。

Twist Express Genes

Twist表达基因

Twist Express Genes are 0.3kb to 5.0kb in length. Due to scale enabled by Twist’s platform, orders of any size both small and large can be filled, and as with standard speed Twist Clonal Genes, Twist Express Genes are NGS sequence-verified as one hundred percent accurate. Twist Express Genes can be cloned into catalog vectors or custom vectors so that customers can move right to experimentation.

Twist表达基因的长度为0.3kb至5.0kb。由于Twist平台能够实现规模化，因此可以填充任何大小的订单，无论大小，并且与标准速度的Twist克隆基因一样，Twist表达基因的NGS序列被验证为100%准确。Twist Express基因可以克隆到目录载体或定制载体中，以便客户可以直接进行实验。

They can also be shipped in customers’ preferred delivery formats, including tubes and plates. For more information and product specifications click here..

它们也可以以客户首选的交付格式发货，包括管子和盘子。有关更多信息和产品规格，请单击此处。。

Current turnaround times for some Twist Bioscience products:

一些Twist生物科学产品的当前周转时间：

Express Genes1 (50ng-10µg): starting at 5 business days, now for up to 10µg

Express Genes1（50ng-10g）：从5个工作日开始，现在最多10g

Standard Clonal Genes (50ng-10µg): starting at 10 business days

标准克隆基因（50ng-10g）：从10个工作日开始

Express Genes1 (10µg-1mg): starting at 8 business days

Express Genes1（10µg-1mg）：从8个工作日开始

Standard Clonal Genes (10µg-1mg): starting at 13 business days

标准克隆基因（10g-1mg）：从13个工作日开始

Twist quantified the minimal carbon footprint of manufacturing a single gene in its 2023 ESG report. View the report here: https://www.twistbioscience.com/company/esg?tab=environmental

Twist在其2023年ESG报告中量化了制造单个基因的最小碳足迹。在此处查看报告：https://www.twistbioscience.com/company/esg?tab=environmental

1 Express Clonal Genes ship in 5-7 business days. DNA prep sizes including 10 μg - 100 μg, and 100 μg - 1 mg may incur an additional 3-5 days for synthesis. Orders placed outside of the US will incur additional delivery turnaround time. Express Genes orders that require new custom vector onboarding will incur an additional 1-2 weeks for processing..

1表达克隆基因在5-7个工作日内发货。DNA制备尺寸（包括10μg-100μg和100μg-1 mg）可能需要额外的3-5天才能合成。在美国境外下的订单将需要额外的交货周转时间。需要新的定制载体登机的Express Genes订单将需要额外1-2周的处理时间。。

About Twist Bioscience Corporation

关于Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip.

Twist Bioscience是一家领先且快速发展的合成生物学和基因组学公司，该公司开发了破坏性DNA合成平台，以实现生物学工程的工业化。该平台的核心是一项专有技术，它开创了一种通过在硅芯片上“写入”DNA来制造合成DNA的新方法。

Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery.

Twist正在利用其独特的技术制造广泛的基于DNA的合成产品，包括合成基因，用于下一代测序（NGS）制备的工具以及用于药物发现和开发的抗体库。Twist还在DNA和生物制剂药物发现的数字数据存储方面寻求长期机会。

Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research..

Twist生产的产品适用于许多行业，包括医疗保健、工业化学品、农业和学术研究。。

Follow us on Twitter | Facebook | LinkedIn | YouTube | Instagram

在Twitter | Facebook | LinkedIn | YouTube | Instagram上关注我们

Twist Bioscience Legal Notice Regarding Forward-Looking Statements

Twist Bioscience关于前瞻性声明的法律公告

This press release contains forward-looking statements. All statements other than statements of historical facts contained herein are forward-looking statements reflecting the current beliefs and expectations of management made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements regarding the turnaround time of the Twist Express Gene offering for midiprep and maxiprep DNA preparations, and Twist Bioscience’s ability to service pharmaceutical, biotechnology, academic and industrial chemical researchers using genes for large scale experimentation.

本新闻稿包含前瞻性声明。除历史事实陈述外，本文所载的所有陈述均为前瞻性陈述，反映了管理层根据1995年《私人证券诉讼改革法案》的安全港条款所做出的当前信念和期望，包括但不限于，关于Twist Express基因为midiprep和maxiprep DNA制剂提供周转时间的声明，以及Twist Bioscience使用基因为制药，生物技术，学术和工业化学研究人员提供大规模实验服务的能力。

Forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause Twist Bioscience’s actual results, performance, or achievements to be materially different from any future results, performance, or achievements expressed or implied by the forward-looking statements.

前瞻性陈述涉及已知和未知的风险、不确定性和其他重要因素，这些因素可能导致Twist Bioscience的实际结果、表现或成就与前瞻性陈述所表达或暗示的任何未来结果、表现或成就有重大差异。

Such risks and uncertainties include, among others, the ability to achieve the expected benefits of Twist Bioscience’s restructuring activities and reduced investments in DNA data storage; the ability to attract new customers and retain and grow sales from existing customers; the ability of Twist Bioscience to achieve sufficient revenue to achieve or maintain positive cash flow from operations or profitability in any given period; risks and uncertainties of rapidly changing technologies and extensive competition in synthetic biology that could make the products Twist Bioscience is developing obsolete or non-competitive; uncertainties of the retention of significant customers; the ability of Twist Bioscience to successfully integrate acquired companies and to achieve expected benefits from acquisitions; supply chain and other disrup.

这些风险和不确定性包括实现Twist Bioscience重组活动预期收益的能力以及减少DNA数据存储投资的能力；吸引新客户、保留和增加现有客户销售额的能力；Twist Bioscience在任何给定时期取得足够收入以实现或维持运营或盈利能力产生的正现金流的能力；快速变化的技术的风险和不确定性以及合成生物学中可能使产品扭曲的广泛竞争生物科学正在发展过时或无竞争力；重要客户保留的不确定性；Twist Bioscience成功整合被收购公司并从收购中获得预期收益的能力；供应链和其他破坏。